Cargando…

Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tung, Lan-Fang, Shen, Sheng-Yeh, Shih, Hui-Hsuan, Chen, Yen-Ting, Yen, Chia-te, Ho, Shu-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158083/
https://www.ncbi.nlm.nih.gov/pubmed/32293463
http://dx.doi.org/10.1186/s12931-020-1328-z
_version_ 1783522466753150976
author Tung, Lan-Fang
Shen, Sheng-Yeh
Shih, Hui-Hsuan
Chen, Yen-Ting
Yen, Chia-te
Ho, Shu-Chuan
author_facet Tung, Lan-Fang
Shen, Sheng-Yeh
Shih, Hui-Hsuan
Chen, Yen-Ting
Yen, Chia-te
Ho, Shu-Chuan
author_sort Tung, Lan-Fang
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation (AE). Patients with AECOPD experience increased dyspnea sensations and systemic inflammation during exercise training. High-flow nasal therapy (HFNT) reduces the minute volume, lowers the respiratory rate, and decreases the work of breathing. However, it is not clear whether HFNT is efficient during exercise training. In this study, we investigated the effects of HFNT during exercise training in an early PR program among hospitalized patients with severe AECOPD. METHODS: We enrolled COPD patients hospitalized due to AE. They were randomized into two groups according to their status into HFNT PR and non-HFNT PR groups. This study collected basic data, and also assessed a pulmonary function test, 6-min walking test, blood inflammatory biomarkers, and arterial gas analysis at the baseline, and at 4 and 12 weeks of the intervention. Data were analyzed using SPSS statistical software. RESULT: We recruited 44 AECOPD patients who completed the 12-week PR program. The HFNT PR program produced significant improvements in exercise tolerance as assessed by the 6-min walking distance (6MWD), reduced dyspnea sensations in the modified Medical Research Council (mMRC), and decreased systemic inflammation as evidenced by the a lower C-reactive protein (CRP) level. A reduction in the length of hospitalization was achieved with PR in the 1-year follow-up in the two groups. The HFNT PR group showed better trends of reduced air trapping in the delta inspiration capacity (IC) and an increased quality of life according to the COPD assessment test (CAT) than did the non-HFNT PR group. CONCLUSIONS: HFNT during exercise training in early PR increases exercise tolerance and reduces systemic inflammation in hospitalized patients with severe AECOPD.
format Online
Article
Text
id pubmed-7158083
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71580832020-04-21 Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study Tung, Lan-Fang Shen, Sheng-Yeh Shih, Hui-Hsuan Chen, Yen-Ting Yen, Chia-te Ho, Shu-Chuan Respir Res Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation (AE). Patients with AECOPD experience increased dyspnea sensations and systemic inflammation during exercise training. High-flow nasal therapy (HFNT) reduces the minute volume, lowers the respiratory rate, and decreases the work of breathing. However, it is not clear whether HFNT is efficient during exercise training. In this study, we investigated the effects of HFNT during exercise training in an early PR program among hospitalized patients with severe AECOPD. METHODS: We enrolled COPD patients hospitalized due to AE. They were randomized into two groups according to their status into HFNT PR and non-HFNT PR groups. This study collected basic data, and also assessed a pulmonary function test, 6-min walking test, blood inflammatory biomarkers, and arterial gas analysis at the baseline, and at 4 and 12 weeks of the intervention. Data were analyzed using SPSS statistical software. RESULT: We recruited 44 AECOPD patients who completed the 12-week PR program. The HFNT PR program produced significant improvements in exercise tolerance as assessed by the 6-min walking distance (6MWD), reduced dyspnea sensations in the modified Medical Research Council (mMRC), and decreased systemic inflammation as evidenced by the a lower C-reactive protein (CRP) level. A reduction in the length of hospitalization was achieved with PR in the 1-year follow-up in the two groups. The HFNT PR group showed better trends of reduced air trapping in the delta inspiration capacity (IC) and an increased quality of life according to the COPD assessment test (CAT) than did the non-HFNT PR group. CONCLUSIONS: HFNT during exercise training in early PR increases exercise tolerance and reduces systemic inflammation in hospitalized patients with severe AECOPD. BioMed Central 2020-04-15 2020 /pmc/articles/PMC7158083/ /pubmed/32293463 http://dx.doi.org/10.1186/s12931-020-1328-z Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tung, Lan-Fang
Shen, Sheng-Yeh
Shih, Hui-Hsuan
Chen, Yen-Ting
Yen, Chia-te
Ho, Shu-Chuan
Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title_full Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title_fullStr Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title_full_unstemmed Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title_short Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
title_sort effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe aecopd: a randomized controlled study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158083/
https://www.ncbi.nlm.nih.gov/pubmed/32293463
http://dx.doi.org/10.1186/s12931-020-1328-z
work_keys_str_mv AT tunglanfang effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy
AT shenshengyeh effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy
AT shihhuihsuan effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy
AT chenyenting effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy
AT yenchiate effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy
AT hoshuchuan effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy